1. Home
  2. WRN vs AUTL Comparison

WRN vs AUTL Comparison

Compare WRN & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WRN
  • AUTL
  • Stock Information
  • Founded
  • WRN 2006
  • AUTL 2014
  • Country
  • WRN Canada
  • AUTL United Kingdom
  • Employees
  • WRN N/A
  • AUTL N/A
  • Industry
  • WRN Metal Mining
  • AUTL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • WRN Basic Materials
  • AUTL Health Care
  • Exchange
  • WRN Nasdaq
  • AUTL Nasdaq
  • Market Cap
  • WRN 435.6M
  • AUTL 433.8M
  • IPO Year
  • WRN N/A
  • AUTL 2018
  • Fundamental
  • Price
  • WRN $2.08
  • AUTL $1.54
  • Analyst Decision
  • WRN Strong Buy
  • AUTL Strong Buy
  • Analyst Count
  • WRN 2
  • AUTL 5
  • Target Price
  • WRN $4.13
  • AUTL $9.12
  • AVG Volume (30 Days)
  • WRN 1.5M
  • AUTL 2.9M
  • Earning Date
  • WRN 11-05-2025
  • AUTL 11-13-2025
  • Dividend Yield
  • WRN N/A
  • AUTL N/A
  • EPS Growth
  • WRN N/A
  • AUTL N/A
  • EPS
  • WRN N/A
  • AUTL N/A
  • Revenue
  • WRN N/A
  • AUTL $29,934,000.00
  • Revenue This Year
  • WRN N/A
  • AUTL $641.63
  • Revenue Next Year
  • WRN N/A
  • AUTL $109.21
  • P/E Ratio
  • WRN N/A
  • AUTL N/A
  • Revenue Growth
  • WRN N/A
  • AUTL 185.17
  • 52 Week Low
  • WRN $0.90
  • AUTL $1.11
  • 52 Week High
  • WRN $2.56
  • AUTL $4.69
  • Technical
  • Relative Strength Index (RSI)
  • WRN 51.43
  • AUTL 46.45
  • Support Level
  • WRN $2.00
  • AUTL $1.51
  • Resistance Level
  • WRN $2.19
  • AUTL $1.67
  • Average True Range (ATR)
  • WRN 0.15
  • AUTL 0.10
  • MACD
  • WRN -0.05
  • AUTL -0.01
  • Stochastic Oscillator
  • WRN 15.79
  • AUTL 11.86

About WRN Western Copper and Gold Corporation

Western Copper & Gold Corp is a Canada-based exploration-stage company. The company is engaged in the exploration and development of the Casino mineral property located in Yukon, Canada (the Casino Project).

About AUTL Autolus Therapeutics plc

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Share on Social Networks: